NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF

The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals, processes for the preparation thereof, and compositions useful for pharmaceutical applications. The size of the nanoparticles according to the inven...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ÖTVÖS, ZSOLT, HELTOVICS, GÁBOR, FILIPCSEI, GENOVÉVA, DARVAS, FERENC
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ÖTVÖS, ZSOLT
HELTOVICS, GÁBOR
FILIPCSEI, GENOVÉVA
DARVAS, FERENC
description The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals, processes for the preparation thereof, and compositions useful for pharmaceutical applications. The size of the nanoparticles according to the invention is smaller than 500 nm. Indomethacine (INN) or Indomethacine (USAN, previously BAN) is a non-steroidal anti-inflammatory drug (NSAID), which is used for the treatment of fever, inflammation, spasm, swells and inflammations. The machanism of action of Indomethacine is the inhibition of the synthesis of prostaglandin. It is marketed under the trade names of Indocin, Indocid, Indochron E-R, and Indocin-SR. La présente invention concerne une composition nanostructurée (nanoparticulaire) comprenant de l'indométacine, ses sels pharmaceutiquement acceptables et ses co-cristaux, ainsi que ses procédés de préparation, et des compositions utiles pour des applications pharmaceutiques. La taille des nanoparticules selon la présente invention est inférieure à 500 nm. L'indométacine (INN) ou l'indométacine (USAN, précédemment BAN) est un médicament anti-inflammatoire non stéroïdien (AINS) utilisé dans le traitement de la fièvre, des inflammations, des spasmes, des gonflements et des inflammations. Le mécanisme d'action de l'indométacine est l'inhibition de la synthèse de la prostaglandine. L'indométacine est commercialisée sous les dénominations commerciales Indocin, Indocid, Indochron, E-R, et Indocin-SR.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015128685A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015128685A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015128685A13</originalsourceid><addsrcrecordid>eNqNjUsKwkAQRLNxIeodBtwqGEVx27YdMzCZHno6iKsQZFyJCnoST2z8HMBV1YNHVT97evAcVWrUWmhrkKvA0apl_-lio_U7Y_2WK9IS0HqaGKvRhBKkAqRaLYJzBwOIFBQ2jkwE1xng33tTlENUcF8OwkgxmoLFaEkdUwCBz1_HQlwMs96pPd_T6JeDbFyQYjlNt2uT7rf2mC7p0ex5PsuX-Xy9Wi8hX_xnvQBrXUK_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF</title><source>esp@cenet</source><creator>ÖTVÖS, ZSOLT ; HELTOVICS, GÁBOR ; FILIPCSEI, GENOVÉVA ; DARVAS, FERENC</creator><creatorcontrib>ÖTVÖS, ZSOLT ; HELTOVICS, GÁBOR ; FILIPCSEI, GENOVÉVA ; DARVAS, FERENC</creatorcontrib><description>The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals, processes for the preparation thereof, and compositions useful for pharmaceutical applications. The size of the nanoparticles according to the invention is smaller than 500 nm. Indomethacine (INN) or Indomethacine (USAN, previously BAN) is a non-steroidal anti-inflammatory drug (NSAID), which is used for the treatment of fever, inflammation, spasm, swells and inflammations. The machanism of action of Indomethacine is the inhibition of the synthesis of prostaglandin. It is marketed under the trade names of Indocin, Indocid, Indochron E-R, and Indocin-SR. La présente invention concerne une composition nanostructurée (nanoparticulaire) comprenant de l'indométacine, ses sels pharmaceutiquement acceptables et ses co-cristaux, ainsi que ses procédés de préparation, et des compositions utiles pour des applications pharmaceutiques. La taille des nanoparticules selon la présente invention est inférieure à 500 nm. L'indométacine (INN) ou l'indométacine (USAN, précédemment BAN) est un médicament anti-inflammatoire non stéroïdien (AINS) utilisé dans le traitement de la fièvre, des inflammations, des spasmes, des gonflements et des inflammations. Le mécanisme d'action de l'indométacine est l'inhibition de la synthèse de la prostaglandine. L'indométacine est commercialisée sous les dénominations commerciales Indocin, Indocid, Indochron, E-R, et Indocin-SR.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150903&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015128685A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150903&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015128685A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ÖTVÖS, ZSOLT</creatorcontrib><creatorcontrib>HELTOVICS, GÁBOR</creatorcontrib><creatorcontrib>FILIPCSEI, GENOVÉVA</creatorcontrib><creatorcontrib>DARVAS, FERENC</creatorcontrib><title>NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF</title><description>The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals, processes for the preparation thereof, and compositions useful for pharmaceutical applications. The size of the nanoparticles according to the invention is smaller than 500 nm. Indomethacine (INN) or Indomethacine (USAN, previously BAN) is a non-steroidal anti-inflammatory drug (NSAID), which is used for the treatment of fever, inflammation, spasm, swells and inflammations. The machanism of action of Indomethacine is the inhibition of the synthesis of prostaglandin. It is marketed under the trade names of Indocin, Indocid, Indochron E-R, and Indocin-SR. La présente invention concerne une composition nanostructurée (nanoparticulaire) comprenant de l'indométacine, ses sels pharmaceutiquement acceptables et ses co-cristaux, ainsi que ses procédés de préparation, et des compositions utiles pour des applications pharmaceutiques. La taille des nanoparticules selon la présente invention est inférieure à 500 nm. L'indométacine (INN) ou l'indométacine (USAN, précédemment BAN) est un médicament anti-inflammatoire non stéroïdien (AINS) utilisé dans le traitement de la fièvre, des inflammations, des spasmes, des gonflements et des inflammations. Le mécanisme d'action de l'indométacine est l'inhibition de la synthèse de la prostaglandine. L'indométacine est commercialisée sous les dénominations commerciales Indocin, Indocid, Indochron, E-R, et Indocin-SR.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUsKwkAQRLNxIeodBtwqGEVx27YdMzCZHno6iKsQZFyJCnoST2z8HMBV1YNHVT97evAcVWrUWmhrkKvA0apl_-lio_U7Y_2WK9IS0HqaGKvRhBKkAqRaLYJzBwOIFBQ2jkwE1xng33tTlENUcF8OwkgxmoLFaEkdUwCBz1_HQlwMs96pPd_T6JeDbFyQYjlNt2uT7rf2mC7p0ex5PsuX-Xy9Wi8hX_xnvQBrXUK_</recordid><startdate>20150903</startdate><enddate>20150903</enddate><creator>ÖTVÖS, ZSOLT</creator><creator>HELTOVICS, GÁBOR</creator><creator>FILIPCSEI, GENOVÉVA</creator><creator>DARVAS, FERENC</creator><scope>EVB</scope></search><sort><creationdate>20150903</creationdate><title>NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF</title><author>ÖTVÖS, ZSOLT ; HELTOVICS, GÁBOR ; FILIPCSEI, GENOVÉVA ; DARVAS, FERENC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015128685A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ÖTVÖS, ZSOLT</creatorcontrib><creatorcontrib>HELTOVICS, GÁBOR</creatorcontrib><creatorcontrib>FILIPCSEI, GENOVÉVA</creatorcontrib><creatorcontrib>DARVAS, FERENC</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ÖTVÖS, ZSOLT</au><au>HELTOVICS, GÁBOR</au><au>FILIPCSEI, GENOVÉVA</au><au>DARVAS, FERENC</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF</title><date>2015-09-03</date><risdate>2015</risdate><abstract>The invention relates to a nanostructured (nanoparticular) composition comprising Indomethacine, its pharmaceutically acceptable salts and co-crystals, processes for the preparation thereof, and compositions useful for pharmaceutical applications. The size of the nanoparticles according to the invention is smaller than 500 nm. Indomethacine (INN) or Indomethacine (USAN, previously BAN) is a non-steroidal anti-inflammatory drug (NSAID), which is used for the treatment of fever, inflammation, spasm, swells and inflammations. The machanism of action of Indomethacine is the inhibition of the synthesis of prostaglandin. It is marketed under the trade names of Indocin, Indocid, Indochron E-R, and Indocin-SR. La présente invention concerne une composition nanostructurée (nanoparticulaire) comprenant de l'indométacine, ses sels pharmaceutiquement acceptables et ses co-cristaux, ainsi que ses procédés de préparation, et des compositions utiles pour des applications pharmaceutiques. La taille des nanoparticules selon la présente invention est inférieure à 500 nm. L'indométacine (INN) ou l'indométacine (USAN, précédemment BAN) est un médicament anti-inflammatoire non stéroïdien (AINS) utilisé dans le traitement de la fièvre, des inflammations, des spasmes, des gonflements et des inflammations. Le mécanisme d'action de l'indométacine est l'inhibition de la synthèse de la prostaglandine. L'indométacine est commercialisée sous les dénominations commerciales Indocin, Indocid, Indochron, E-R, et Indocin-SR.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2015128685A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title NANOSTRUCTURED COMPOSITION COMPRISING INDOMETHACINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND CO-CRYSTALS AND PROCESS FOR THE PREPARATION THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T15%3A43%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=%C3%96TV%C3%96S,%20ZSOLT&rft.date=2015-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015128685A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true